Similar articles for PMID: 22272904

Year	Number of Results
1947	1
2001	1
2002	2
2003	1
2004	4
2005	4
2006	5
2007	5
2008	6
2009	9
2010	8
2011	7
2012	8
2013	8
2014	10
2015	7
2017	6
2018	2
2019	2
2020	4
2021	7
2022	6
2023	2
2024	0

1

Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease.

Zhou Z, Yee DL, Guchhait P. Zhou Z, et al. Curr Vasc Pharmacol. 2012 Nov;10(6):756-61. doi: 10.2174/157016112803520738. Curr Vasc Pharmacol. 2012. PMID: 22272904 Review.

2

Role of extracellular hemoglobin in thrombosis and vascular occlusion in patients with sickle cell anemia.

Zhou Z, Behymer M, Guchhait P. Zhou Z, et al. Anemia. 2011;2011:918916. doi: 10.1155/2011/918916. Epub 2010 Dec 27. Anemia. 2011. PMID: 21490767 Free PMC article.

3

The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.

Chen J, Hobbs WE, Le J, Lenting PJ, de Groot PG, López JA. Chen J, et al. Blood. 2011 Mar 31;117(13):3680-3. doi: 10.1182/blood-2010-08-302539. Epub 2011 Feb 7. Blood. 2011. PMID: 21300978 Free PMC article.

4

Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.

Zhou Z, Han H, Cruz MA, López JA, Dong JF, Guchhait P. Zhou Z, et al. Thromb Haemost. 2009 Jun;101(6):1070-7. Thromb Haemost. 2009. PMID: 19492149

5

Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.

Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA. Zhang X, et al. Science. 2009 Jun 5;324(5932):1330-4. doi: 10.1126/science.1170905. Science. 2009. PMID: 19498171 Free PMC article.

6

Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.

Sins JWR, Schimmel M, Luken BM, Nur E, Zeerleder SS, van Tuijn CFJ, Brandjes DPM, Kopatz WF, Urbanus RT, Meijers JCM, Biemond BJ, Fijnvandraat K. Sins JWR, et al. J Thromb Haemost. 2017 Jul;15(7):1392-1402. doi: 10.1111/jth.13728. Epub 2017 Jun 5. J Thromb Haemost. 2017. PMID: 28457019 Free article.

7

Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.

Chenou F, Hounkpe BW, Domingos IF, Tonassé WV, Batista THC, Santana RM, Arcanjo GDS, Alagbe AE, Araújo ADS, Lucena-Araújo AR, Bezerra MAC, Costa FF, Sonati MF, De Paula EV, Dos Santos MNN. Chenou F, et al. Ann Hematol. 2021 Nov;100(11):2669-2676. doi: 10.1007/s00277-021-04636-3. Epub 2021 Aug 28. Ann Hematol. 2021. PMID: 34453189

8

ADAMTS13 activity in sickle cell disease.

Schnog JJ, Kremer Hovinga JA, Krieg S, Akin S, Lämmle B, Brandjes DP, Mac Gillavry MR, Muskiet FD, Duits AJ; CURAMA Study Group. Schnog JJ, et al. Am J Hematol. 2006 Jul;81(7):492-8. doi: 10.1002/ajh.20653. Am J Hematol. 2006. PMID: 16755558 Free article. Clinical Trial.

9

Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.

Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Villagra J, et al. Blood. 2007 Sep 15;110(6):2166-72. doi: 10.1182/blood-2006-12-061697. Epub 2007 May 29. Blood. 2007. PMID: 17536019 Free PMC article.

10

Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.

Al-Awadhi A, Adekile A, Marouf R. Al-Awadhi A, et al. Acta Haematol. 2021;144(2):182-189. doi: 10.1159/000508521. Epub 2020 Sep 28. Acta Haematol. 2021. PMID: 32987383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year